Literature DB >> 19000672

Proteomic analysis of the nuclear matrix in the early stages of rat liver carcinogenesis: identification of differentially expressed and MAR-binding proteins.

Paola Barboro1, Cristina D'Arrigo, Erica Repaci, Luca Bagnasco, Paola Orecchia, Barbara Carnemolla, Eligio Patrone, Cecilia Balbi.   

Abstract

Tumor progression is characterized by definite changes in the protein composition of the nuclear matrix (NM). The interactions of chromatin with the NM occur via specific DNA sequences called MARs (matrix attachment regions). In the present study, we applied a proteomic approach along with a Southwestern assay to detect both differentially expressed and MAR-binding NM proteins, in persistent hepatocyte nodules (PHN) in respect with normal hepatocytes (NH). In PHN, the NM undergoes changes both in morphology and in protein composition. We detected over 500 protein spots in each two dimensional map and 44 spots were identified. Twenty-three proteins were differentially expressed; among these, 15 spots were under-expressed and 8 spots were over-expressed in PHN compared to NH. These changes were synchronous with several modifications in both NM morphology and the ability of NM proteins to bind nuclear RNA and/or DNA containing MARs sequences. In PHN, we observed a general decrease in the expression of the basic proteins that bound nuclear RNA and the over-expression of two species of Mw 135 kDa and 81 kDa and pI 6.7-7.0 and 6.2-7.4, respectively, which exclusively bind to MARs. These results suggest that the deregulated expression of these species might be related to large-scale chromatin reorganization observed in the process of carcinogenesis by modulating the interaction between MARs and the scaffold structure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19000672     DOI: 10.1016/j.yexcr.2008.10.017

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  Specialized compartments of cardiac nuclei exhibit distinct proteomic anatomy.

Authors:  Sarah Franklin; Michael J Zhang; Haodong Chen; Anna K Paulsson; Scherise A Mitchell-Jordan; Yifeng Li; Peipei Ping; Thomas M Vondriska
Journal:  Mol Cell Proteomics       Date:  2010-08-31       Impact factor: 5.911

2.  Nuclear matrix association: switching to the invasive cytotrophoblast.

Authors:  K J Drennan; A K Linnemann; A E Platts; H H Heng; D R Armant; S A Krawetz
Journal:  Placenta       Date:  2010-03-25       Impact factor: 3.481

3.  Subnuclear domain proteins in cancer cells support the functions of RUNX2 in the DNA damage response.

Authors:  Seungchan Yang; Alexandre J C Quaresma; Jeffrey A Nickerson; Karin M Green; Scott A Shaffer; Anthony N Imbalzano; Lori A Martin-Buley; Jane B Lian; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  J Cell Sci       Date:  2015-01-20       Impact factor: 5.285

4.  Role and molecular mechanism of heterogeneous nuclear ribonucleoprotein K in tumor development and progression.

Authors:  Jing Lu; Feng-Hou Gao
Journal:  Biomed Rep       Date:  2016-03-29

5.  Dysregulation of miR-212 Promotes Castration Resistance through hnRNPH1-Mediated Regulation of AR and AR-V7: Implications for Racial Disparity of Prostate Cancer.

Authors:  Yijun Yang; Dingwu Jia; Hogyoung Kim; Zakaria Y Abd Elmageed; Amrita Datta; Rodney Davis; Sudesh Srivastav; Krzysztof Moroz; Byron E Crawford; Krishnarao Moparty; Raju Thomas; Robert S Hudson; Stefan Ambs; Asim B Abdel-Mageed
Journal:  Clin Cancer Res       Date:  2015-11-09       Impact factor: 12.531

6.  The role of nuclear matrix proteins binding to matrix attachment regions (Mars) in prostate cancer cell differentiation.

Authors:  Paola Barboro; Erica Repaci; Cristina D'Arrigo; Cecilia Balbi
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

7.  Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance.

Authors:  Carmela Ricciardelli; Noor A Lokman; Carmen E Pyragius; Miranda P Ween; Anne M Macpherson; Andrew Ruszkiewicz; Peter Hoffmann; Martin K Oehler
Journal:  Oncotarget       Date:  2017-03-14

8.  Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer.

Authors:  P Barboro; E Repaci; A Rubagotti; S Salvi; S Boccardo; B Spina; M Truini; C Introini; P Puppo; N Ferrari; G Carmignani; F Boccardo; C Balbi
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

9.  Androgen receptor activity is affected by both nuclear matrix localization and the phosphorylation status of the heterogeneous nuclear ribonucleoprotein K in anti-androgen-treated LNCaP cells.

Authors:  Paola Barboro; Luana Borzì; Erica Repaci; Nicoletta Ferrari; Cecilia Balbi
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.